Tamara Prodanov
YOU?
Author Swipe
View article: Biochemical Diagnosis of Phaeochromocytoma and Paraganglioma in Children and Adolescents: A Retrospective Cohort Study
Biochemical Diagnosis of Phaeochromocytoma and Paraganglioma in Children and Adolescents: A Retrospective Cohort Study Open
Introduction Currently, it is unclear whether plasma free or 24‐h urinary fractionated metanephrines are preferable for diagnosis of phaeochromocytoma/paraganglioma (PPGL) in children. Objectives To investigate whether measurements of plas…
View article: A case series of three patients with extensive lung metastatic pheochromocytoma/paraganglioma: evaluation, treatment challenges, and outcomes
A case series of three patients with extensive lung metastatic pheochromocytoma/paraganglioma: evaluation, treatment challenges, and outcomes Open
Pheochromocytomas (PCCs) and paragangliomas (PGLs; together PPGLs) are uncommon neuroendocrine tumors arising from adrenal medullary chromaffin cells and sympathetic/parasympathetic paraganglia. Though PPGLs predominate in adult population…
View article: 8498 Nicardipine: Safe and Effective in Treating Catecholamine-Induced Hypertension?
8498 Nicardipine: Safe and Effective in Treating Catecholamine-Induced Hypertension? Open
Disclosure: M. Nazari: None. R. Hasan: None. T. Prodanov: None. K. Charles: None. A. Jha: None. A. Park: None. S. Talvacchio: None. A. Derkyi: None. M. Kuo: None. M. Patel: None. A. Dey: None. A.S. Alzahrani: None. K. Pacak: None. Backgrou…
View article: 8338 A Case Series of 3 Patients with Unusual Miliary Lung Metastases in Paraganglioma: Diagnostic Workup, Treatment Challenges and Outcomes
8338 A Case Series of 3 Patients with Unusual Miliary Lung Metastases in Paraganglioma: Diagnostic Workup, Treatment Challenges and Outcomes Open
Disclosure: K.M. Charles: None. M.A. Nazari: None. A. Jha: None. A. Derkyi: None. S. Talvacchio: None. M.J. Kuo: None. M. Patel: None. T. Prodanov: None. A.S. Alzahrani: None. A. Chen: None. J. Glod: None. J. Del Rivero: None. A.M. Gharib:…
View article: 8338 A Case Series Of 3 Patients With Unusual Miliary Lung Metastases In Paraganglioma: Diagnostic Workup, Treatment Challenges And Outcomes
8338 A Case Series Of 3 Patients With Unusual Miliary Lung Metastases In Paraganglioma: Diagnostic Workup, Treatment Challenges And Outcomes Open
Disclosure: K.M. Charles: None. M.A. Nazari: None. A. Jha: None. A. Derkyi: None. S. Talvacchio: None. M.J. Kuo: None. M. Patel: None. T. Prodanov: None. A.S. Alzahrani: None. A. Chen: None. J. Glod: None. J. Del Rivero: None. A.M. Gharib:…
View article: Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma
Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma Open
Few reports have highlighted the rare presence of somatic ATRX variants in clinically aggressive, metastatic pheochromocytoma/paraganglioma (PCC/PGL); however, none have addressed detailed clinical presentation (including biochemistry and …
View article: Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles Open
Hereditary SDHB-mutant pheochromocytomas (PC) and paragangliomas (PG) are rare tumours with a high propensity to metastasize although their clinical behaviour is unpredictable. To characterize the genomic landscape of these tumours and ide…
View article: Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma
Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma Open
Objective To compare the diagnostic performance of [ 68 Ga]DOTATATE PET/CT, [ 18 F]FDG PET/CT, MRI of the spine, and whole-body CT and MRI for the detection of pheochromocytoma/paraganglioma (PPGL)–related spinal bone metastases. Materials…
View article: SAT305 Clinical Characteristics And Outcomes Of Patient With Metastatic Pheochromocytoma/Paraganglioma (PPGL) And Extreme Elevated Biochemistry
SAT305 Clinical Characteristics And Outcomes Of Patient With Metastatic Pheochromocytoma/Paraganglioma (PPGL) And Extreme Elevated Biochemistry Open
Disclosure: T. Prodanov: None. A. Jha: None. S. Talvacchio: None. M. Nazari, MD: None. K. Pacak, MD, PhD: None. Background: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrinetumors arising from chromaffin cells in adrenal…
View article: Paediatric phaeochromocytoma and paraganglioma: A clinical update
Paediatric phaeochromocytoma and paraganglioma: A clinical update Open
Paediatric phaeochromocytomas and paragangliomas (PPGLs), though rare tumours, are associated with significant disability and death in the most vulnerable of patients early in their lives. However, unlike cryptogenic and insidious disease …
View article: Data from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Data from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma Open
Purpose: Pheochromocytomas (PCC) and paragangliomas (PGL) are genetically heterogeneous neural crest–derived neoplasms. Recently we identified germline mutations in a new tumor suppressor susceptibility gene, MAX (MYC-associated factor X),…
View article: Supplementary Figures 1 - 3 from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Supplementary Figures 1 - 3 from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma Open
PDF file, 794KB, Supplementary figure S1. Gross MAX deletion analysis Supplementary figure S2. Immunohistochemical assessment. Supplementary figure S3. Pedigree of 3 families with affected relatives in more than one generation.
View article: Supplementary Figures 1 - 3 from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Supplementary Figures 1 - 3 from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma Open
PDF file, 794KB, Supplementary figure S1. Gross MAX deletion analysis Supplementary figure S2. Immunohistochemical assessment. Supplementary figure S3. Pedigree of 3 families with affected relatives in more than one generation.
View article: Data from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Data from <i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma Open
Purpose: Pheochromocytomas (PCC) and paragangliomas (PGL) are genetically heterogeneous neural crest–derived neoplasms. Recently we identified germline mutations in a new tumor suppressor susceptibility gene, MAX (MYC-associated factor X),…
View article: PSUN27 Largest Cohort of Cervical Spine Metastases of Pheochromocytoma/Paraganglioma in the Setting of SDHB Mutation
PSUN27 Largest Cohort of Cervical Spine Metastases of Pheochromocytoma/Paraganglioma in the Setting of SDHB Mutation Open
Background Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors arising from chromaffin cells in adrenal or extra-adrenal locations, respectively. Overall, 10 to 20% of PPGLs are metastatic, with higher metastatic po…
View article: Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma
Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma Open
Context Long-term follow-up has been recommended for patients with pheochromocytoma or paraganglioma (PPGL) due to potential for recurrent disease. However, the need to follow patients with sporadic PPGL has recently become controversial. …
View article: Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma
Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma Open
Supplemental Appendix for manuscript 'Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma'
View article: Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma
Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma Open
Supplemental Appendix for manuscript 'Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma'
View article: Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma
Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma Open
Supplemental Appendix for manuscript 'Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma'
View article: Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma
Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma Open
Supplemental Appendix for manuscript 'Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma'
View article: Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma
Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma Open
Supplemental Appendix for manuscript 'Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma'
View article: Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma
Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma Open
Supplemental Appendix for manuscript 'Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma'